Use of depth filters to remove prion infectivity from plasma - derived therapeutic products and/or other biologics. Depth Filtration is a chemically inactive process and therefore does not introduce potentially toxic bi-products or alter components. More

Proprietary manufacturing process for a liquid IVIgG product - in great demand world-wide as one of the principal therapeutics obtained from blood plasma. Process delivers a low IgA content, which increases renal tolerability. More

Proprietary process to produce a freeze-dried fibrinogen therapeutic product, easily soluble. Includes two virus inactivation processes: dry heat treatment and solvent/detergent. More

Novel process for production of thrombin and thrombin preparations capable of being produced in a freeze dried form, which may be heat-treated to inactivate any viruses present. More

The invention teaches a step - charge in yielding improvement over the Cohn process, widely applicable to immunoglobulin manufacture. More